HEADER TRANSCRIPTION 22-JUN-07 2QE4 TITLE ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH A TITLE 2 BENZOPYRAN AGONIST COMPND MOL_ID: 1; COMPND 2 MOLECULE: ESTROGEN RECEPTOR; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: LIGAND BINDING DOMAIN; COMPND 5 SYNONYM: ER, ESTRADIOL RECEPTOR, ER-ALPHA; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ESR1, ESR, NR3A1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID KEYWDS NUCLEAR RECEPTOR, LIGAND-BINDING DOMAIN, ALTERNATIVE SPLICING, DNA- KEYWDS 2 BINDING, LIPID-BINDING, METAL-BINDING, NUCLEAR PROTEIN, KEYWDS 3 PHOSPHORYLATION, POLYMORPHISM, STEROID-BINDING, TRANSCRIPTION, KEYWDS 4 TRANSCRIPTION REGULATION, ZINC, ZINC-FINGER EXPDTA X-RAY DIFFRACTION AUTHOR B.H.NORMAN,T.I.RICHARDSON,J.A.DODGE,L.A.PFEIFER,G.L.DURST,Y.WANG, AUTHOR 2 J.D.DURBIN,V.KRISHNAN,S.R.DINN,S.Q.LIU,J.E.REILLY,K.T.RYTER REVDAT 4 21-FEB-24 2QE4 1 REMARK REVDAT 3 20-OCT-21 2QE4 1 SEQADV REVDAT 2 24-FEB-09 2QE4 1 VERSN REVDAT 1 04-SEP-07 2QE4 0 JRNL AUTH B.H.NORMAN,T.I.RICHARDSON,J.A.DODGE,L.A.PFEIFER,G.L.DURST, JRNL AUTH 2 Y.WANG,J.D.DURBIN,V.KRISHNAN,S.R.DINN,S.LIU,J.E.REILLY, JRNL AUTH 3 K.T.RYTER JRNL TITL BENZOPYRANS AS SELECTIVE ESTROGEN RECEPTOR BETA AGONISTS JRNL TITL 2 (SERBAS). PART 4: FUNCTIONALIZATION OF THE BENZOPYRAN JRNL TITL 3 A-RING. JRNL REF BIOORG.MED.CHEM.LETT. V. 17 5082 2007 JRNL REFN ISSN 0960-894X JRNL PMID 17662603 JRNL DOI 10.1016/J.BMCL.2007.07.009 REMARK 2 REMARK 2 RESOLUTION. 2.40 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNX 2005 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN,ACCELRYS REMARK 3 : SOFTWARE INC.(BADGER,BERARD,KUMAR,SZALMA, REMARK 3 : YIP,DZAKULA) REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 47.98 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 1689182.580 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 93.3 REMARK 3 NUMBER OF REFLECTIONS : 17216 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.241 REMARK 3 R VALUE (WORKING SET) : 0.241 REMARK 3 FREE R VALUE : 0.279 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.900 REMARK 3 FREE R VALUE TEST SET COUNT : 1020 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.009 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL WITH ALL DATA. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : NULL REMARK 3 FREE R VALUE (NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE (NO CUTOFF) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.40 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.55 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 82.90 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2382 REMARK 3 BIN R VALUE (WORKING SET) : 0.2610 REMARK 3 BIN FREE R VALUE : 0.2960 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 6.10 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 155 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.024 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3274 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 48 REMARK 3 SOLVENT ATOMS : 31 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 29.90 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 46.60 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -12.29000 REMARK 3 B22 (A**2) : 9.26000 REMARK 3 B33 (A**2) : 3.03000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -1.84000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.32 REMARK 3 ESD FROM SIGMAA (A) : 0.26 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.39 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.31 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 1.200 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 19.70 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.740 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.490 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.470 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.270 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 3.410 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.38 REMARK 3 BSOL : 43.72 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PAR REMARK 3 PARAMETER FILE 2 : PROTEIN.TOP REMARK 3 PARAMETER FILE 3 : WATER_REP.PAR REMARK 3 PARAMETER FILE 4 : ION.PARAM REMARK 3 PARAMETER FILE 5 : LIG.PAR REMARK 3 PARAMETER FILE 6 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 TOPOLOGY FILE 2 : NULL REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 TOPOLOGY FILE 6 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2QE4 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 23-JUL-07. REMARK 100 THE DEPOSITION ID IS D_1000043483. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 10-JUL-03 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.8 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 210 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 17217 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.400 REMARK 200 RESOLUTION RANGE LOW (A) : 47.980 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.540 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 93.5 REMARK 200 DATA REDUNDANCY : 2.700 REMARK 200 R MERGE (I) : 0.06300 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 16.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.40 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.49 REMARK 200 COMPLETENESS FOR SHELL (%) : 80.8 REMARK 200 DATA REDUNDANCY IN SHELL : 2.30 REMARK 200 R MERGE FOR SHELL (I) : 0.30100 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.550 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 41.13 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.09 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100 MM MES PH 6.8, 0.5 M MGCL2, 15% REMARK 280 W/V PEG 4000, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 51.95750 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 27.04550 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 51.95750 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 27.04550 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE ASU FORMS A BIOLOGICAL ASSEMBLY (DIMER). REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2990 ANGSTROM**2 REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ASN A 304 REMARK 465 SER A 305 REMARK 465 TYR A 331 REMARK 465 ASP A 332 REMARK 465 PRO A 333 REMARK 465 THR A 334 REMARK 465 ARG A 335 REMARK 465 PHE A 461 REMARK 465 LEU A 462 REMARK 465 SER A 463 REMARK 465 SER A 464 REMARK 465 THR A 465 REMARK 465 LEU A 466 REMARK 465 LYS A 467 REMARK 465 SER A 468 REMARK 465 LEU A 469 REMARK 465 GLU A 470 REMARK 465 GLU A 471 REMARK 465 LYS A 529 REMARK 465 SER A 530 REMARK 465 LYS A 531 REMARK 465 ASN A 532 REMARK 465 VAL A 533 REMARK 465 VAL A 534 REMARK 465 PRO A 535 REMARK 465 LEU A 536 REMARK 465 TYR A 537 REMARK 465 ASP A 538 REMARK 465 LEU A 539 REMARK 465 LEU A 540 REMARK 465 LEU A 541 REMARK 465 GLU A 542 REMARK 465 MET A 543 REMARK 465 LEU A 544 REMARK 465 ASP A 545 REMARK 465 ALA A 546 REMARK 465 HIS A 547 REMARK 465 ARG A 548 REMARK 465 LEU A 549 REMARK 465 HIS A 550 REMARK 465 ALA A 551 REMARK 465 ASN B 304 REMARK 465 SER B 305 REMARK 465 TYR B 331 REMARK 465 ASP B 332 REMARK 465 PRO B 333 REMARK 465 THR B 334 REMARK 465 ARG B 335 REMARK 465 PRO B 336 REMARK 465 PHE B 337 REMARK 465 SER B 338 REMARK 465 GLU B 339 REMARK 465 ALA B 340 REMARK 465 LEU B 462 REMARK 465 SER B 463 REMARK 465 SER B 464 REMARK 465 THR B 465 REMARK 465 LEU B 466 REMARK 465 LYS B 467 REMARK 465 SER B 468 REMARK 465 LEU B 469 REMARK 465 GLU B 470 REMARK 465 LYS B 529 REMARK 465 SER B 530 REMARK 465 LYS B 531 REMARK 465 ASN B 532 REMARK 465 VAL B 533 REMARK 465 VAL B 534 REMARK 465 PRO B 535 REMARK 465 LEU B 536 REMARK 465 TYR B 537 REMARK 465 ASP B 538 REMARK 465 LEU B 539 REMARK 465 LEU B 540 REMARK 465 LEU B 541 REMARK 465 GLU B 542 REMARK 465 MET B 543 REMARK 465 LEU B 544 REMARK 465 ASP B 545 REMARK 465 ALA B 546 REMARK 465 HIS B 547 REMARK 465 ARG B 548 REMARK 465 LEU B 549 REMARK 465 HIS B 550 REMARK 465 ALA B 551 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 323 130.31 -37.15 REMARK 500 PRO A 365 117.09 -39.41 REMARK 500 HIS A 398 72.30 -108.67 REMARK 500 ASN A 407 30.16 -89.50 REMARK 500 LEU A 408 73.93 -161.72 REMARK 500 GLU B 323 126.25 -39.63 REMARK 500 GLU B 397 35.92 -99.10 REMARK 500 HIS B 398 61.91 -154.65 REMARK 500 LEU B 408 62.97 -156.77 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2Q70 RELATED DB: PDB REMARK 900 ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN COMPLEXED TO A REMARK 900 BENZOPYRAN LIGAND. REMARK 900 RELATED ID: 2I0J RELATED DB: PDB REMARK 900 BENZOPYRANS ARE SELECTIVE ESTROGEN RECEPTOR BETA AGONISTS (SERBAS) REMARK 900 WITH NOVEL ACTIVITY IN MODELS OF BENIGN PROSTATIC HYPERPLASIA REMARK 900 RELATED ID: 2POG RELATED DB: PDB REMARK 900 BENZOPYRANS AS SELECTIVE ESTROGEN RECEPTOR B AGONISTS (SERBAS). REMARK 900 PART 2: STRUCTURE ACTIVITY RELATIONSHIP STUDIES ON THE BENZOPYRAN REMARK 900 SCAFFOLD. DBREF 2QE4 A 304 551 UNP P03372 ESR1_HUMAN 304 551 DBREF 2QE4 B 304 551 UNP P03372 ESR1_HUMAN 304 551 SEQADV 2QE4 SER A 381 UNP P03372 CYS 381 ENGINEERED MUTATION SEQADV 2QE4 SER A 417 UNP P03372 CYS 417 ENGINEERED MUTATION SEQADV 2QE4 SER A 530 UNP P03372 CYS 530 ENGINEERED MUTATION SEQADV 2QE4 SER B 381 UNP P03372 CYS 381 ENGINEERED MUTATION SEQADV 2QE4 SER B 417 UNP P03372 CYS 417 ENGINEERED MUTATION SEQADV 2QE4 SER B 530 UNP P03372 CYS 530 ENGINEERED MUTATION SEQRES 1 A 248 ASN SER LEU ALA LEU SER LEU THR ALA ASP GLN MET VAL SEQRES 2 A 248 SER ALA LEU LEU ASP ALA GLU PRO PRO ILE LEU TYR SER SEQRES 3 A 248 GLU TYR ASP PRO THR ARG PRO PHE SER GLU ALA SER MET SEQRES 4 A 248 MET GLY LEU LEU THR ASN LEU ALA ASP ARG GLU LEU VAL SEQRES 5 A 248 HIS MET ILE ASN TRP ALA LYS ARG VAL PRO GLY PHE VAL SEQRES 6 A 248 ASP LEU THR LEU HIS ASP GLN VAL HIS LEU LEU GLU SER SEQRES 7 A 248 ALA TRP LEU GLU ILE LEU MET ILE GLY LEU VAL TRP ARG SEQRES 8 A 248 SER MET GLU HIS PRO GLY LYS LEU LEU PHE ALA PRO ASN SEQRES 9 A 248 LEU LEU LEU ASP ARG ASN GLN GLY LYS SER VAL GLU GLY SEQRES 10 A 248 MET VAL GLU ILE PHE ASP MET LEU LEU ALA THR SER SER SEQRES 11 A 248 ARG PHE ARG MET MET ASN LEU GLN GLY GLU GLU PHE VAL SEQRES 12 A 248 CYS LEU LYS SER ILE ILE LEU LEU ASN SER GLY VAL TYR SEQRES 13 A 248 THR PHE LEU SER SER THR LEU LYS SER LEU GLU GLU LYS SEQRES 14 A 248 ASP HIS ILE HIS ARG VAL LEU ASP LYS ILE THR ASP THR SEQRES 15 A 248 LEU ILE HIS LEU MET ALA LYS ALA GLY LEU THR LEU GLN SEQRES 16 A 248 GLN GLN HIS GLN ARG LEU ALA GLN LEU LEU LEU ILE LEU SEQRES 17 A 248 SER HIS ILE ARG HIS MET SER ASN LYS GLY MET GLU HIS SEQRES 18 A 248 LEU TYR SER MET LYS SER LYS ASN VAL VAL PRO LEU TYR SEQRES 19 A 248 ASP LEU LEU LEU GLU MET LEU ASP ALA HIS ARG LEU HIS SEQRES 20 A 248 ALA SEQRES 1 B 248 ASN SER LEU ALA LEU SER LEU THR ALA ASP GLN MET VAL SEQRES 2 B 248 SER ALA LEU LEU ASP ALA GLU PRO PRO ILE LEU TYR SER SEQRES 3 B 248 GLU TYR ASP PRO THR ARG PRO PHE SER GLU ALA SER MET SEQRES 4 B 248 MET GLY LEU LEU THR ASN LEU ALA ASP ARG GLU LEU VAL SEQRES 5 B 248 HIS MET ILE ASN TRP ALA LYS ARG VAL PRO GLY PHE VAL SEQRES 6 B 248 ASP LEU THR LEU HIS ASP GLN VAL HIS LEU LEU GLU SER SEQRES 7 B 248 ALA TRP LEU GLU ILE LEU MET ILE GLY LEU VAL TRP ARG SEQRES 8 B 248 SER MET GLU HIS PRO GLY LYS LEU LEU PHE ALA PRO ASN SEQRES 9 B 248 LEU LEU LEU ASP ARG ASN GLN GLY LYS SER VAL GLU GLY SEQRES 10 B 248 MET VAL GLU ILE PHE ASP MET LEU LEU ALA THR SER SER SEQRES 11 B 248 ARG PHE ARG MET MET ASN LEU GLN GLY GLU GLU PHE VAL SEQRES 12 B 248 CYS LEU LYS SER ILE ILE LEU LEU ASN SER GLY VAL TYR SEQRES 13 B 248 THR PHE LEU SER SER THR LEU LYS SER LEU GLU GLU LYS SEQRES 14 B 248 ASP HIS ILE HIS ARG VAL LEU ASP LYS ILE THR ASP THR SEQRES 15 B 248 LEU ILE HIS LEU MET ALA LYS ALA GLY LEU THR LEU GLN SEQRES 16 B 248 GLN GLN HIS GLN ARG LEU ALA GLN LEU LEU LEU ILE LEU SEQRES 17 B 248 SER HIS ILE ARG HIS MET SER ASN LYS GLY MET GLU HIS SEQRES 18 B 248 LEU TYR SER MET LYS SER LYS ASN VAL VAL PRO LEU TYR SEQRES 19 B 248 ASP LEU LEU LEU GLU MET LEU ASP ALA HIS ARG LEU HIS SEQRES 20 B 248 ALA HET JJ3 A 601 24 HET JJ3 B 601 24 HETNAM JJ3 (3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-6-(METHOXYMETHYL)-1,2, HETNAM 2 JJ3 3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL FORMUL 3 JJ3 2(C20 H22 O4) FORMUL 5 HOH *31(H2 O) HELIX 1 1 LEU A 306 LEU A 310 5 5 HELIX 2 2 THR A 311 GLU A 323 1 13 HELIX 3 3 SER A 338 ARG A 363 1 26 HELIX 4 4 THR A 371 SER A 395 1 25 HELIX 5 5 ASN A 413 LYS A 416 5 4 HELIX 6 6 MET A 421 MET A 438 1 18 HELIX 7 7 GLN A 441 SER A 456 1 16 HELIX 8 8 LYS A 472 ALA A 493 1 22 HELIX 9 9 THR A 496 TYR A 526 1 31 HELIX 10 10 THR B 311 GLU B 323 1 13 HELIX 11 11 SER B 341 LYS B 362 1 22 HELIX 12 12 GLY B 366 LEU B 370 5 5 HELIX 13 13 THR B 371 SER B 395 1 25 HELIX 14 14 ARG B 412 SER B 417 1 6 HELIX 15 15 GLY B 420 ASN B 439 1 20 HELIX 16 16 GLN B 441 GLY B 457 1 17 HELIX 17 17 GLU B 471 GLY B 494 1 24 HELIX 18 18 THR B 496 SER B 527 1 32 SHEET 1 A 2 LYS A 401 ALA A 405 0 SHEET 2 A 2 LEU A 408 ASP A 411 -1 O LEU A 410 N LEU A 402 SHEET 1 B 2 LYS B 401 ALA B 405 0 SHEET 2 B 2 LEU B 408 ASP B 411 -1 O LEU B 410 N LEU B 402 CRYST1 103.915 54.091 84.169 90.00 91.24 90.00 C 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009623 0.000000 0.000209 0.00000 SCALE2 0.000000 0.018487 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011884 0.00000